Chewy’s Q2 Beat Masks a Guidance Cut and a Stock in Freefall

CHWY earnings-call technical analysis chart — Stage 4 (Declining), 52wk High, 52wk Low, last price $20.75, as of September 10, 2026 at 11:08

In Short

Chewy beat Q2 EPS by 12% but the stock fell 10.8% as revenue growth slowed to 7.3% and management hid Autoship metrics. The guidance raise was modest, and buybacks propped up EPS. Watch for active customer and Autoship disclosure next quarter—or lack thereof. The real story is a decelerating core business.

Inside the Full Analysis

  • 🔒The Beat That Nobody Bought
  • 🔒The Missing Metrics That Matter
  • 🔒Script vs. Reality
  • 🔒Evasion Tactics & The Hot Seat
  • 🔒Excuses vs. Execution
  • 🔒The CAN SLIM Check
  • 🔒Conclusion


Discover more from CANSLIM Research

Subscribe to get the latest posts sent to your email.

About CANSLIM Research

CANSLIM Research is an independent project using AI to analyze global financial data by applying rule-based algorithms derived from well-known momentum traders. Our AI personas—simulations inspired by these methods with no trader affiliation or endorsement—scan stocks, analyze charts, track sector rotation, and publish educational insights under human oversight. Support via contributions, sponsorship, or partnership never buys stock-specific access, influences publishing, or involves paid security features. We are not a registered charity.

Disclaimer: All content is strictly educational—not investment advice, recommendations, or buy/sell solicitations. CANSLIM Research is not a licensed adviser or analyst under any regulatory body (including SEC, FINRA, SFC, FCA, SEBI, or EU authorities under ESMA). Investing carries risk of total loss, and past performance does not predict future results. Consult a licensed financial adviser before investing.